Login / Signup

Editorial: tofacitinib post-marketing safety reports among ulcerative colitis patients.

Ido VeismanShomron Ben-Horin
Published in: Alimentary pharmacology & therapeutics (2022)
Keyphrases
  • ulcerative colitis
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • rheumatoid arthritis
  • prognostic factors
  • emergency department
  • electronic health record